Bacterial Overgrowth in the Gastrointestinal Tract
Understanding Bacterial Overgrowth
- The small intestine normally maintains relatively low bacterial counts, and overgrowth here represents a distinct pathological state 1
- Gastric bacterial overgrowth can occur when the normal acid barrier is compromised, such as when proton pump inhibitors reduce gastric acid secretion 1, 2
- Colonic bacterial alterations differ from SIBO, manifesting as dysbiosis—qualitative changes in bacterial composition rather than quantitative overgrowth 3, 4
- Studies in IBS patients show depletion of beneficial anaerobes, such as Bacteroides, Bifidobacterium, Lactobacillus, and Eubacterium, rather than simple overgrowth 4, 5
Protective Mechanisms
- The gastric acid barrier prevents bacterial colonization of the stomach and proximal small intestine 1, 2
- The migrating motor complex (MMC) clears intestinal debris from the small intestine, preventing bacterial stasis 1, 2
- The ileocecal valve prevents reflux of colonic bacteria backward into the small intestine 1, 2
- Pancreatic and biliary secretions provide bacteriostatic properties in the small intestine 1
- Local intestinal immunity, through immunoglobulin secretion, helps control bacterial populations 1
Clinical Implications
- A patient can have gastric bacterial overgrowth from PPI use without meeting criteria for SIBO 1, 2
- Colonic dysbiosis in IBS patients represents altered bacterial composition, not SIBO, despite similar symptoms 3, 4
- Breath testing abnormalities often reflect rapid transit with colonic fermentation rather than true small intestinal overgrowth 4, 5
- SIBO treatment focuses on antibiotics, such as rifaximin 550mg twice daily for 1-2 weeks, targeting small intestinal bacteria 2
- Gastric bacterial overgrowth may require addressing PPI use rather than antibiotics 1, 2
- Colonic dysbiosis may benefit from dietary modification and prebiotics rather than antibiotics 4, 5